Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-380277
Filing Date
2026-09-02
Accepted
2026-09-02 16:30:26
Documents
1
Period of Report
2026-08-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 17360
  Complete submission text file 0001193125-26-380277.txt   18746
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 650-481-6801
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1 W. FIRST AVENUE CONSHOHOCKEN PA 19428
Business Address
Kim Lorence H. (Reporting) CIK: 0001643746 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 261355304